<?xml version="1.0" encoding="ISO-8859-1"?>
<entity-relation-data lastUpdate="2023-03-27 17:22:43" record="42306" source="Espacenet">
	<entities>
		<entity ref="Patent42306" type="Patent">
			<semanticIdentifier>brcris::125e2f748397e5551be7dd52896457ac</semanticIdentifier>
			<semanticIdentifier>docdb::BR132017021795E2</semanticIdentifier>
			<semanticIdentifier>epodoc::BR132017021795E</semanticIdentifier>
			<semanticIdentifier>docdb::BR132017021795A</semanticIdentifier>
			<semanticIdentifier>epodoc::BR20171321795</semanticIdentifier>
			<semanticIdentifier>original::132017021795</semanticIdentifier>
			<field name="urlEspacenet" value="https://worldwide.espacenet.com/patent/search?q=132017021795"/>
			<field name="identifier.lattes" value="6277013725246341"/>
			<field name="identifier.espacenet" value="132017021795"/>
			<field name="kindCode" value="E2"/>
			<field name="title.espacenet" value="formulação de antirretroviral em nanopartículas poliméricas para o tratamento de hiv/aids e respectivos ensaios de toxicidade, permeabilidade in vitro e biodistribuição in vivo"/>
			<field name="title.lattes" value="Formulação de antirretroviral em nanopartículas poliméricas para o tratamento de HIV/AIDS e respectivos ensaios de toxicidade, permeabilidade in vitro e biodistribuição in vivo. Certificado de adição à patente BR1020130180890"/>
			<field name="depositDate" value="2017-10-10"/>
			<field name="publicationDate" value="2019-05-14"/>
			<field name="countryCode" value="BR"/>
			<field name="inventor" value="ARMANDO DA SILVA CUNHA JUNIOR"/>
			<field name="inventor" value="BRENDA FERNANDA MOREIRA CASTRO"/>
			<field name="inventor" value="MILENA CRISTINA RIBEIRO SOUZA MAGALHAES"/>
			<field name="inventor" value="SILVIA LIGORIO FIALHO"/>
			<field name="applicant" value="FUNDACAO DE AMPARO A PESQUISA DO ESTADO DE MINAS GERAIS - FAPEMIG"/>
			<field name="applicant" value="FUNDACAO EZEQUIEL DIAS"/>
			<field name="applicant" value="UNIVERSIDADE FEDERAL DE MINAS GERAIS - UFMG"/>
			<field name="classification.ipc">
				<field name="sequence" value="1"/>
				<field name="text" value="A61K9/51AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="K"/>
				<field name="group" value="9"/>
				<field name="subgroup" value="51AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="2"/>
				<field name="text" value="A61K31/7072AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="K"/>
				<field name="group" value="31"/>
				<field name="subgroup" value="7072AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="3"/>
				<field name="text" value="A61K47/34AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="K"/>
				<field name="group" value="47"/>
				<field name="subgroup" value="34AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="4"/>
				<field name="text" value="A61P31/18AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="P"/>
				<field name="group" value="31"/>
				<field name="subgroup" value="18AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="5"/>
				<field name="text" value="B82Y5/00AI"/>
				<field name="section" value="B"/>
				<field name="class" value="82"/>
				<field name="subclass" value="Y"/>
				<field name="group" value="5"/>
				<field name="subgroup" value="00AI"/>
			</field>
			<field name="abstract.espacenet" value="a presente invenção diz respeito a uma formulação farmacêutica capaz de tratar e controlar a infecção pelo vírus da imunodeficiência humana (hiv), causador da síndrome da imunodeficiência adquirida (aids). a dita formulação é composta principalmente por nanopartículas poliméricas de policaprolactona e um agente antirretroviral. a invenção se refere ainda a nanopartículas poliméricas de policaprolactona contendo um agente antirretroviral que não apresenta toxicidade para linfócitos, possui permeabilidade de aproximadamente duas vezes superior quando comparado a uma formulação convencional e apresenta níveis plasmáticos elevados e constantes após administração oral em camundongos."/>
			<field name="originatesFrom" value="67253583"/>
			<field name="alternateIdentifier">
				<field name="status" value="Publication"/>
				<field name="format" value="docdb"/>
				<field name="country" value="BR"/>
				<field name="number" value="132017021795"/>
				<field name="kind" value="E2"/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Publication"/>
				<field name="format" value="epodoc"/>
				<field name="country" value="BR"/>
				<field name="number" value="BR132017021795E"/>
				<field name="kind" value=""/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="docdb"/>
				<field name="country" value="BR"/>
				<field name="number" value="132017021795"/>
				<field name="kind" value="A"/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="epodoc"/>
				<field name="country" value="BR"/>
				<field name="number" value="BR20171321795"/>
				<field name="kind" value=""/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="original"/>
				<field name="country" value=""/>
				<field name="number" value="132017021795"/>
				<field name="kind" value=""/>
			</field>
		</entity>
		<entity ref="Person28869" type="Person">
			<semanticIdentifier>lattes::6277013725246341</semanticIdentifier>
			<field name="identifier.lattes" value="6277013725246341"/>
			<field name="name" value="Sílvia Ligório Fialho"/>
		</entity>
		<entity ref="OrgUnit22576" type="OrgUnit">
			<semanticIdentifier>brcris::aadbd5889f0d9f0c34ec2323c0a15104</semanticIdentifier>
			<field name="name" value="FUNDACAO EZEQUIEL DIAS"/>
		</entity>
	</entities>
	<relations>
		<relation fromEntityRef="Patent42306" toEntityRef="Person28869" type="Inventor"/>
		<relation fromEntityRef="Patent42306" toEntityRef="OrgUnit22576" type="Applicant"/>
	</relations>
</entity-relation-data>
